1. Home
  2. HUSA vs CING Comparison

HUSA vs CING Comparison

Compare HUSA & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houston American Energy Corporation

HUSA

Houston American Energy Corporation

HOLD

Current Price

$2.14

Market Cap

339.8M

Sector

Energy

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.41

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUSA
CING
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.8M
26.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HUSA
CING
Price
$2.14
$4.41
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
288.6K
119.5K
Earning Date
11-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$225,678.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.96
$3.20
52 Week High
$12.70
$6.01

Technical Indicators

Market Signals
Indicator
HUSA
CING
Relative Strength Index (RSI) 22.16 71.13
Support Level $1.96 $3.75
Resistance Level $2.34 $4.02
Average True Range (ATR) 0.35 0.21
MACD -0.11 0.07
Stochastic Oscillator 5.17 96.30

Price Performance

Historical Comparison
HUSA
CING

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: